Issue |
Title |
File |
Vol 92, No 11 (2020) |
Risks of oncologic pathology in parasitosis at the present time |
(Rus)
|
Omarova K.G., Aleshina N.I., Ponezhevа Z.B., Gorelov A.V., Maleev V.V., Akimkin V.G.
|
Vol 92, No 11 (2020) |
Current view on Blastocystis species: clinical forms, diagnosis and treatment |
(Rus)
|
Maleev V.V., Tokmalaev A.K., Kozhevnikova G.M., Tsvetkova N.A., Polovinkina N.A., Golub V.P., Maksimova M.S., Barysheva I.V., Konnov V.V., Kharlamova T.V.
|
Vol 92, No 11 (2020) |
Umifenovir and coronavirus infections: a review of research results and clinical practice |
(Rus)
|
Leneva I.A., Pshenichnaya N.Y., Bulgakova V.A.
|
Vol 92, No 11 (2020) |
The role of vitamin D in seasonal acute respiratory viral infections and COVID-19 |
(Rus)
|
Pigarova E.A., Povalyaeva A.A., Dzeranova L.K., Rozhinskaya L.Y., Mokrysheva N.G.
|
Vol 92, No 11 (2020) |
Urinary tract infections in patients with type 2 diabetes mellitus with pharmacological glucosuria |
(Rus)
|
Sturov N.V., Popov S.V., Mamporia N.K., Mager A.A.
|
Vol 92, No 10 (2020) |
The prevalence of autoimmune endocrine diseases in vitiligo patients |
(Rus)
|
Troshina E.A., Volnukhin V.A., Petrov V.A., Nuralieva N.F., Yukina M.Y., Orlova E.M., Frigo N.V.
|
Vol 92, No 10 (2020) |
Gut microbiota is a factor of risk for obesity and type 2 diabetes |
(Rus)
|
Demidova T.Y., Lobanova K.G., Oinotkinova O.S.
|
Vol 92, No 9 (2020) |
Choosing of therapy for a patient with dorsalgia |
(Rus)
|
Kamchatnov P.R., Abusueva B.A., Khanmurzaeva S.B., Khanmurzaeva N.B.
|
Vol 92, No 9 (2020) |
Changes in the intestinal microbiota as a risk factor for dyslipidemia, atherosclerosis and the role of probiotics in their prevention |
(Rus)
|
Oynotkinova O.S., Nikonov E.L., Demidova T.Y., Baranov A.P., Kryukov E.V., Dedov E.I., Karavashkina E.A.
|
Vol 92, No 9 (2020) |
Diagnostic and prognostic significance of QRS-T angle |
(Rus)
|
Blinova E.V., Sakhnova T.A., Yurasova E.S.
|
Vol 92, No 9 (2020) |
The achievements of the modern specific therapy of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: focus on the stimulator of soluble guanylate cyclase riociguat |
(Rus)
|
Gratsianskaya S.E., Valieva Z.S., Martynyuk T.V.
|
Vol 92, No 9 (2020) |
Role of magnetic resonance imaging in patients with aortic stenosis before and after replacement of the valve |
(Rus)
|
Shariya M.A., Ustyuzhanin D.V., Lepilin P.M., Imaev T.E., Komlev A.E., Belyaevskaya A.A., Ternovoy S.K.
|
Vol 92, No 9 (2020) |
Hypertrophic cardiomyopathy in elderly: causes, diagnostic and treatment approaches |
(Rus)
|
Chumakova O.S.
|
Vol 92, No 9 (2020) |
Problematic aspects of pulmonary hypertension due to left heart disease: focus on combined postcapillary and precapillary pulmonary hypertension |
(Rus)
|
Aleevskaya A.M., Vyborov O.N., Gramovich V.V., Martynyuk T.V.
|
Vol 92, No 9 (2020) |
Decreasing cardiovascular morbidity: how to improve adherence to the treatment in the translational era |
(Rus)
|
Zhirov I.V.
|
Vol 92, No 8 (2020) |
Diet therapy for irritable bowel syndrome |
(Rus)
|
Bakulin I.G., Avalueva E.B., Оrеshkо L.S., Sitkin S.I., Shevyakov M.A., Serkova M.U., Semenova E.A.
|
Vol 92, No 8 (2020) |
Evaluation and management of infectious esophagitis in immunocompromised patients and immunocompetent individuals |
(Rus)
|
Trukhmanov A.S., Makushina A.A., Storonova O.A., Ivashkina N.Y.
|
Vol 95, No 9 (2023) |
Sacubitril/valsartan in patients with mildly reduced or preserved ejection fraction and worsening heart failure: A review |
(Rus)
|
Zhirov I.V., Safronova N.V., Tereshchenko S.N.
|
Vol 95, No 9 (2023) |
Sartans in the treatment of arterial hypertension: focus on telmisartan and azilsartan. A review |
(Rus)
|
Zakiev V.D., Kotovskaya Y.V., Tkacheva O.N.
|
151 - 169 of 169 Items |
<< < 1 2 3 4
|